Karen Theresa Adams, DNP, APRN

**** ********* ******, ***********, *** York 12303

adh81g@r.postjobfree.com 301-***-****

Objective: Looking for a weekend/per diem position to be part of a team of exceptional professionals where I can contribute my expertise and support.

Experience

Doctor of Nursing Practice 10/2020-present

Veterans Administration,

Jamaica Plain, Boston Health Care System

Boston, Massachusetts

Endoscopy Clinical Coordinator, Endoscopy Unit, Jamaica Plain VA location. Supervising the scheduling of patients and providers for several procedures in the GI Department. Supervising the check in process along with monitoring providers orders and COVID results for veterans having procedures. Working as a liaison between interprofessional teams within the VA system for both the Brockton and West Roxbury Campuses.

Doctor of Nursing Practice 4/2019-present

Veterans Administration Outpatient Clinic

Pittsfield, Massachusetts

Doctor of Nursing Practice Primary Care provider, offering comprehensive and acute health care to male and female adults in an adult clinical setting practice for military veterans. Broad knowledge in performing routine health assessments. Highlights to include implementation of and advocacy for preventive health care, medical diagnosis and treatment plans for chronic and acute health problems, women’s health procedures, interpretation of diagnostic and laboratory procedures as well as being the liaison for the community care interprofessional team. Additional roles as clinic smoking cessation, nutrition and pain champion.

Doctor of Nursing Practice 9/2018-3/2019

Landmark Health

Albany, New York

Responsible for managing 250 patients. Providing frontline care to patients in their homes in order to mitigate the likelihood of emergency department visits or primary care provider appointments throughout the greater capital region of New York State.

Doctor of Nursing Practice 9/2017-7/2018

Washington Home and Community Hospice Washington, DC

Conducted administrative visits evaluating 12-14 hospice patients weekly in their homes throughout Washington, DC and Maryland certifying or declining the need for continued hospice services. This was a part time employment held concurrently with a fulltime staff position.

Doctor of Nursing Practice & Program Coordinator, 01/2004-7/2018

National Institutes of Health (NIH)

Pheochromocytoma-Paraganglioma Program Bethesda, Maryland

•Specialized in clinical research on neuroendocrine tumors

•Managed and coordinated clinical care. This included evaluating and scheduling surgical candidates, coordinating patient treatments including chemotherapy, interventional radiology, clinical trials, and tracking post-op care.

•Educated visiting research fellows, nurses, and support staff.

•Intra-professional liaison: Coordinated patient support involvement with oncology, orthopedic oncology, ENT, gastrointestinal, interventional radiology and surgical specialties.

•Supervised diagnostic studies, such as nuclear medicine scans F-Dopamine, FDOPA, DOTATATE; supervised biochemical assessments, as well as clonidine, glucagon, and ACTH tests.

•Supervised clinical fellows and four post-baccalaureate support staff for the clinical practice.

•Assess, evaluate, and treat patients with hypertensive crisis and metastatic Pheochromocytoma / Paraganglioma.

•Drafted correspondence to the NIH Institutional Review Board.

•Global conference presenter at 19 conferences on the effects of Catecholamine Access and Hypertension.

•Associate investigator on Clinical Trial, Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/Paraganglioma.

Nurse Practitioner 11/2016-6/2017

Optum Healthcare Reston, Virginia

Visited healthcare facilities performing medical and physical evaluations, chart review, and interventions on residents (exhibiting a variety of both chronic and end of life issues) in rehabilitation, long-term care, hospice, and assisted living facilities.

Adult Nurse Practitioner, Assistant Professor 08/2003-12/2003

Harrisburg Area Community College

Gettysburg, Pennsylvania

•Clinical instructor: While representing the maternal/child nursing clinic, I was responsible for collaborating with clinical agencies to arrange the clinical experiences in obstetrics and gynecology.

•Supported all student activities related to clinical work, curriculum support and development, and development of appropriate course materials.

•Communicated with host hospital staff and other nursing faculty.

•Supervised 60 nursing students assigned in my course load.

Adult Nurse Practitioner 06/2003-01/2004

Mission of Mercy Medical Van

Fairfield, Pennsylvania

•Volunteered weekly for a medical van which provided full-spectrum diagnosis and treatment for the homeless, uninsured, and indigent populations.

•Collaborated with two physicians and a dentist to diagnose, develop treatment plans, applied treatment, counseled patients, and provided education in a public health environment

•Managed between 20 to 30 patients per eight-hour shift.

Adult Nurse Practitioner 05/2001-04/2003

Family Health Services

Chambersburg, Pennsylvania

•Supervised the diagnosis, treatment, prescription of appropriate therapies, referrals, staff supervision, and follow-up of patients with a primary focus on women’s health issues.

•Provided care and counseling for patients regarding parenting skills, birth control, fertility and pregnancy, sexually transmitted diseases, cancer screening and diagnosing.

•Managed 20 to 30 patients per eight-hour shift.

Adult Nurse Practitioner 06/1997-12/1999

Pitt Anesthesia Associates

Clinton, Maryland

•Performed pre-operative evaluations for all surgical patients at Southern Maryland Hospital Center.

•Worked closely with physicians to determine suitability of patients for surgical procedures.

•Interpreted radiological, laboratory, and other tests to clear patients for surgery.

•Instructed patients on surgery preparation.

•Developed a pamphlet detailing the process from pre-operative testing and admission to post-operative management and discharge, designed for patients to assist them throughout the surgical process.

Adult Nurse Practitioner 08/1996-06/1997

Denise E. Bruner, M.D.

Arlington, Virginia

•Supervised a 40 member staff, evaluated their performance and tracked their training.

•Designed and prescribed treatment plans for patients, with a primary focus on weight loss.

•Fulfilled total “on-call” responsibilities.

•Performed complete physical exams, evaluated patient medical issues and prescribed appropriate treatment and medications.

Registered Nurse 03/1994-06/1996

Syracuse VA Medical Center

Syracuse, New York

Staff Nurse on Medical/Surgical unit.

Registered Nurse 08/1993-03/1994

St. Joseph’s Hospital

Syracuse, New York

Staff Nurse on open heart surgery unit.

Education

Doctor of Nursing Practice 2016

Chamberlain College

Chicago, Illinois

Master of Science in Nursing 1996

Syracuse University

Syracuse, New York

Bachelor of Science Nursing 1993

Russell Sage College

Troy, New York

Bachelor Degree, Business Administration 1989

Niagara University

Niagara, New York

Licenses

Maryland License # R136340

Washington, DC License # RN 1045833

New York # 468065-1

New Hampshire # 077618-23

Massachusetts # RN2337756

Certifications

DEA # N94121 expiration 6/2020

ANCC expires 11/2023

BLS expires 6/2022

NPI # 127507053

Conferences & Memberships

•Presenter at the International Symposium of Pheochromocytoma, Sydney, Australia, August 2017.

•Presenter at the 17th International Congress of Endocrinology and 15th Annual Meeting of Chinese Society of Endocrinology. Beijing, China. September 2016.

•Co-chaired Fourth Annual International Patient Symposium On Pheochromocytoma: Working Together Today for a Better Tomorrow, May, 2016, Washington, DC, Congressman Patrick Murphy opening remarks.

•Presenter at the European Society of Endocrinology Conference, May 2015, Dublin, Ireland.

•Member of the Federation of International Nurses in Endocrinology, 2015-Present.

•Co-Chair for collaborative meeting between National Institutes of Health, Pheochromocytoma/Paraganglioma Program and Hospitales Angeles, Puebla, Mexico, July 2014.

•Co-Chair Third Annual International Patient Symposium On Pheochromocytoma: Working Together Today for a Better Tomorrow, June 2014, Washington, DC.

•Presenter, 10th Asian-Pacific Congress of Hypertension, February, 2014, Cebu City, Philippines.

•Founder, First Annual International Patient Symposium On Pheochromocytoma: Working Together Today for a Better Tomorrow, June, 2013, Washington, DC, Congressman James Moran, opening remarks.

•Presenter, Pheochromocytoma Conference, March, 2012, Mumbai, India.

•Presenter, Asian Alliance for the Study of Neuroendocrine Tumors, November, 2011, Saigon, Vietnam.

•Co-organizer of the Third International Symposium on Pheochromocytoma, September, 2011, Paris, France.

•Chair, Pheo Para Alliance Patient Conference, September, 2009, Parsippany, New Jersey.

•Co-organizer of the Second International Symposium on Pheochromocytoma, October, 2008, Cambridge, United Kingdom.

•Founder, Pheo Para Alliance Cancer Benefit, May 2007- Present, Washington, DC.

•Founder Pheo Para Alliance, 2007.

•Co-Chair, Second Annual National Conference on Pheochromocytoma, September, 2007. Washington, DC.

•Chair, First Annual National Conference on Pheochromocytoma, September, 2006, Washington, DC.

•Committee of the First International Symposium on Pheochromocytoma, October, 2005, Bethesda, Maryland.

Publications

1: Abhishek Jha, Alexander Ling, Corina Millo, Garima Gupta, Bruna Viana, Frank I. Lin, Peter Herscovitch, Karen T. Adams, David Taïeb, Adam R. Metwalli, W. Marston Linehan, Alessandra Brofferio, Constantine A. Stratakis, Electron Kebebew, Maya Lodish, Ali Cahid Civelek, Karel Pacak. Superiority of 68Ga-DOTATATE over 18F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx)-related pheochromocytoma and paraganglioma in the pediatric population. European Journal of Nuclear Medicine and Molecular Imaging. 2017 December. https://doi.org/10.1007/s00259-017-3896-9

2: Jochmanova I, Wolf KI, King KS, Nambuba J, Wesley R, Martucci V, Raygada M, Adams KT, Prodanov T, Fojo AT, Lazurova I, Pacak K. SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations. Journal of Cancer Research and Clinical Oncology 2017 August 143(8):1421-1435. doi: 10.1007/s00432-017-2397-3. Epub 2017 Apr 3. Pubmed PMID: 28374168

3: Janssen I, Chen CC, Zhuang Z, Millo CM, Wolf KI, Ling A, Lin FI, Adams KT, Herscovitch P, Feelders RA, Fojo AT, Taieb D, Kebebew E, Pacak K. Functional Imaging Signature of Patients Presenting with Polycythemia/Paraganglioma Syndromes. J Nucl Med

https://www.ncbi.nlm.nih.gov/pubmed/28336782

2017 Aug;58(8):1236-1242. doi: 10.2967/jnumed.116.187690. Epub 2017 Mar 23. PMID: 28336782

4: Batsis M, Dagalakis U, Stratakis CA, Prodanov T, Papadakis GZ, Adams KT, Lodish

M, Pacak K. Attention Deficit Hyperactivity Disorder in Pediatric Patients with

Pheochromocytoma and Paraganglioma. Horm Metab Res. 2016 May 12. [Epub ahead of

print] PubMed PMID: 27171833.

5: Osinga TE, Xekouki P, Nambuba J, Faucz FR, de la Luz Sierra M, Links TP, Kema

IP, Adams KT, Stratakis CA, van der Horst-Schrivers AN, Pacak K. SDH Subunit

Mutation Status in Saliva: Genetic Testing in Patients with Pheochromocytoma.

Horm Metab Res. 2016 Apr;48(4):247-50. doi: 10.1055/s-003*-*******. Epub 2016 Feb

25. PubMed PMID: 26916530.

6: Vara Luiz H, Tanchee MJ, Pavlatou MG, Yu R, Nambuba J, Wolf K, Prodanov T,

Wesley R, Adams KT, Fojo T, Pacak K. Are patients with hormonally functional

phaeochromocytoma and paraganglioma initially receiving a proper adrenoceptor

blockade? A retrospective cohort study. Clin Endocrinol (Oxf). 2016 Mar 21. doi:

10.1111/cen.13066. [Epub ahead of print] PubMed PMID: 26998836.

7: Janssen I, Chen CC, Millo CM, Ling A, Taieb D, Lin FI, Adams KT, Wolf KI,

Herscovitch P, Fojo AT, Buchmann I, Kebebew E, Pacak K. PET/CT comparing

(68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT/MRI for

the localization of sporadic metastatic pheochromocytoma and paraganglioma. Eur J

Nucl Med Mol Imaging. 2016 Mar 21. [Epub ahead of print] PubMed PMID: 26996779.

8: Turkova H, Prodanov T, Maly M, Martucci V, Adams KT, Widimsky J Jr, Chen CC,

Ling A, Kebebew E, Stratakis CA, Fojo T, Pacak K. CHARACTERISTICS AND OUTCOMES OF METASTATIC SDHB AND SPORADIC PHEOCHROMOCYTOMA/PARAGANGLIOMA: AN NATIONAL

INSTITUTES OF HEALTH STUDY. Endocr Pract. 2016 Mar;22(3):302-14. doi:

10.4158/EP15725.OR. Epub 2015 Nov 2. PubMed PMID: 26523625.

9: Janssen I, Chen CC, Taieb D, Patronas NJ, Millo CM, Adams KT, Nambuba J,

Herscovitch P, Sadowski SM, Fojo AT, Buchmann I, Kebebew E, Pacak K.

68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared

with Other Functional Imaging Modalities and CT/MRI. J Nucl Med. 2016

Feb;57(2):186-91. doi: 10.2967/jnumed.115.161018. Epub 2015 Nov 12. PubMed PMID:

26564322; PubMed Central PMCID: PMC4738157.

10: Janssen I, Blanchet EM, Adams KT, Chen CC, Millo CM, Herscovitch P, Taieb D,

Kebebew E, Lehnert H, Fojo AT, Pacak K. Superiority of [68Ga]-DOTATATE PET/CT to

Other Functional Imaging Modalities in the Localization of SDHB-Associated

Metastatic Pheochromocytoma and Paraganglioma. Clin Cancer Res. 2015 Sep

1;21(17):3888-95. doi: 10.1158/1078-0432.CCR-14-2751. Epub 2015 Apr 14. PubMedPMID: 25873086; PubMed Central PMCID: PMC4558308.

11: Martucci VL, Emaminia A, del Rivero J, Lechan RM, Magoon BT, Galia A, Fojo T,

Leung S, Lorusso R, Jimenez C, Shulkin BL, Audibert JL, Adams KT, Rosing DR,

Vaidya A, Dluhy RG, Horvath KA, Pacak K. Succinate dehydrogenase gene mutations

in cardiac paragangliomas. Am J Cardiol. 2015 Jun 15;115(12):1753-9. doi:

10.1016/j.amjcard.2015.03.020. Epub 2015 Mar 24. PubMed PMID: 25896150; PubMed

Central PMCID: PMC4450109.

12: Raygada M, King KS, Adams KT, Stratakis CA, Pacak K. Counseling patients with

succinate dehydrogenase subunit defects: genetics, preventive guidelines, and

dealing with uncertainty. J Pediatr Endocrinol Metab. 2014 Sep;27(9-10):837-44.

doi: 10.1515/jpem-2013-0369. PubMed PMID: 24854530; PubMed Central PMCID:

PMC4718145.

13: Schovanek J, Martucci V, Wesley R, Fojo T, Del Rivero J, Huynh T, Adams KT,

Kebebew E, Frysak Z, Stratakis CA, Pacak K. The size of the primary tumor and age

at initial diagnosis are independent predictors of the metastatic behavior and

survival of patients with SDHB-related pheochromocytoma and paraganglioma: a

retrospective cohort study. BMC Cancer. 2014 Jul 21;14:523. doi:

10.1186/147*-****-**-***. PubMed PMID: 25048685; PubMed Central PMCID:

PMC4223758.

14: Vogel J, Atanacio AS, Prodanov T, Turkbey BI, Adams KT, Martucci V, Camphausen

K, Fojo AT, Pacak K, Kaushal A. External beam radiation therapy in treatment of

malignant pheochromocytoma and paraganglioma. Front Oncol. 2014 Jun 27;4:166.

doi: 10.3389/fonc.2014.00166. eCollection 2014. PubMed PMID: 25019060; PubMed

Central PMCID: PMC4073229.

15: Ellis RJ, Patel D, Prodanov T, Sadowski S, Nilubol N, Adams KT, Steinberg SM,

Pacak K, Kebebew E. Response after surgical resection of metastatic

pheochromocytoma and paraganglioma: can postoperative biochemical remission be

predicted? J Am Coll Surg. 2013 Sep;217(3):489-96. doi:

10.1016/j.jamcollsurg.2013.04.027. Epub 2013 Jul 25. PubMed PMID: 23891076;

PubMed Central PMCID: PMC3770940.

16: Eisenhofer G, Lenders JW, Siegert G, Bornstein SR, Friberg P, Milosevic D,

Mannelli M, Linehan WM, Adams KT, Timmers HJ, Pacak K. Plasma methoxytyramine: a

novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to

established risk factors of tumour size, location and SDHB mutation status. Eur J

Cancer. 2012 Jul;48(11):1739-49. doi: 10.1016/j.ejca.2011.07.016. Epub 2011 Oct

28. PubMed PMID: 22036874; PubMed Central PMCID: PMC3372624.

17: Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Eisenhofer G, King

KS, Rao JU, Wesley RA, Adams KT, Pacak K. Staging and functional characterization

of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG)

positron emission tomography. J Natl Cancer Inst. 2012 May 2;104(9):700-8. doi:

10.1093/jnci/djs188. Epub 2012 Apr 18. PubMed PMID: 22517990; PubMed Central

PMCID: PMC3341309.

18: Fonte JS, Robles JF, Chen CC, Reynolds J, Whatley M, Ling A, Mercado-Asis LB,

Adams KT, Martucci V, Fojo T, Pacak K. False-negative I-MIBG SPECT is most

commonly found in SDHB-related pheochromocytoma or paraganglioma with high

frequency to develop metastatic disease. Endocr Relat Cancer. 2012 Feb

13;19(1):83-93. doi: 10.1530/ERC-11-0243. Print 2012 Feb. PubMed PMID: 22167067;

PubMed Central PMCID: PMC3420013.

19: Venkatesan AM, Trivedi H, Adams KT, Kebebew E, Pacak K, Hughes MS. Comparison

of clinical and imaging features in succinate dehydrogenase-positive versus

sporadic paragangliomas. Surgery. 2011 Dec;150(6):1186-93. doi:

10.1016/j.surg.2011.09.026. PubMed PMID: 22136839; PubMed Central PMCID:

PMC3635828.

20: King KS, Chen CC, Alexopoulos DK, Whatley MA, Reynolds JC, Patronas N, Ling

A, Adams KT, Xekouki P, Lando H, Stratakis CA, Pacak K. Functional imaging of

SDHx-related head and neck paragangliomas: comparison of

18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine,

18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and

111In-pentetreotide scintigraphy. J Clin Endocrinol Metab. 2011

Sep;96(9):2779-85. doi: 10.1210/jc.2011-0333. Epub 2011 Jul 13. PubMed PMID:

21752889; PubMed Central PMCID: PMC3167674.

21: Eisenhofer G, Lenders JW, Timmers H, Mannelli M, Grebe SK, Hofbauer LC,

Bornstein SR, Tiebel O, Adams KT, Bratslavsky G, Linehan WM, Pacak K. Measurements

of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of

different hereditary forms of pheochromocytoma. Clin Chem. 2011 Mar;57(3):411-20.

doi: 10.1373/clinchem.2010.153320. Epub 2011 Jan 24. PubMed PMID: 21262951;

PubMed Central PMCID: PMC3164998.

22: Lodish MB, Adams KT, Huynh TT, Prodanov T, Ling A, Chen C, Shusterman S,

Jimenez C, Merino M, Hughes M, Cradic KW, Milosevic D, Singh RJ, Stratakis CA,

Pacak K. Succinate dehydrogenase gene mutations are strongly associated with

paraganglioma of the organ of Zuckerkandl. Endocr Relat Cancer. 2010 Jun

3;17(3):581-8. doi: 10.1677/ERC-10-0004. Print 2010 Sep. PubMed PMID: 20418362;

PubMed Central PMCID: PMC3417306.

23: King KS, Darmani NA, Hughes MS, Adams KT, Pacak K. Exercise-induced nausea

and vomiting: another sign and symptom of pheochromocytoma and paraganglioma.

Endocrine. 2010 Jun;37(3):403-7. doi: 10.1007/s12020-010-9319-3. Epub 2010 Apr

21. PubMed PMID: 20960160; PubMed Central PMCID: PMC4130359.

24: Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Havekes B,

Eisenhofer G, Martiniova L, Adams KT, Pacak K. Comparison of 18F-fluoro-L-DOPA,

18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in

the localization of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab.

2009 Dec;94(12):4757-67. doi: 10.1210/jc.2009-1248. Epub 2009 Oct 28. PubMed

PMID: 19864450; PubMed Central PMCID: PMC2795662.

25: Venkatesan AM, Locklin J, Lai EW, Adams KT, Fojo AT, Pacak K, Wood BJ.

Radiofrequency ablation of metastatic pheochromocytoma. J Vasc Interv Radiol.

2009 Nov;20(11):1483-90. doi: 10.1016/j.jvir.2009.07.031. PubMed PMID: 19875067;

PubMed Central PMCID: PMC3608423.

26: He J, Makey D, Fojo T, Adams KT, Havekes B, Eisenhofer G, Sullivan P, Lai EW,

Pacak K. Successful chemotherapy of hepatic metastases in a case of succinate

dehydrogenase subunit B-related paraganglioma. Endocrine. 2009 Oct;36(2):189-93.

doi: 10.1007/s12020-009-9219-6. Epub 2009 Jul 18. PubMed PMID: 19618298; PubMed

Central PMCID: PMC4713025.

27: Timmers HJ, Eisenhofer G, Carrasquillo JA, Chen CC, Whatley M, Ling A, Adams

KT, Pacak K. Use of 6-[18F]-fluorodopamine positron emission tomography (PET) as

first-line investigation for the diagnosis and localization of non-metastatic and

metastatic phaeochromocytoma (PHEO). Clin Endocrinol (Oxf). 2009 Jul;71(1):11-7.

doi: 10.1111/j.1365-2265.2008.03496.x. Epub 2008 Dec 5. PubMed PMID: 19138315;

PubMed Central PMCID: PMC2713382.

28: Prodanov T, Havekes B, Nathanson KL, Adams KT, Pacak K. Malignant

paraganglioma associated with succinate dehydrogenase subunit B in an 8-year-old

child: the age of first screening? Pediatr Nephrol. 2009 Jun;24(6):1239-42. doi:

10.1007/s00467-008-1111-8. Epub 2009 Feb 3. PubMed PMID: 19189136; PubMed Central

PMCID: PMC4714580.

29: Havekes B, Romijn JA, Eisenhofer G, Adams KT, Pacak K. Update on pediatric

pheochromocytoma. Pediatr Nephrol. 2009 May;24(5):943-50. doi:

10.1007/s00467-008-0888-9. Epub 2008 Jun 20. Review. PubMed PMID: 18566838.

30: Solis DC, Burnichon N, Timmers HJ, Raygada MJ, Kozupa A, Merino MJ, Makey D,

Adams KT, Venisse A, Gimenez-Roqueplo AP, Pacak K. Penetrance and clinical

consequences of a gross SDHB deletion in a large family. Clin Genet. 2009

Apr;75(4):354-63. doi: 10.1111/j.1399-0004.2009.01157.x. PubMed PMID: 19389109;

PubMed Central PMCID: PMC4718153.

31: Ghayee HK, Havekes B, Corssmit EP, Eisenhofer G, Hammes SR, Ahmad Z, Tessnow

A, Lazúrová I, Adams KT, Fojo AT, Pacak K, Auchus RJ. Mediastinal paragangliomas:

association with mutations in the succinate dehydrogenase genes and aggressive

behavior. Endocr Relat Cancer. 2009 Mar;16(1):291-9. doi: 10.1677/ERC-08-0214.

Epub 2008 Dec 15. PubMed PMID: 19075037; PubMed Central PMCID: PMC4718401.

32: Baid SK, Lai EW, Wesley RA, Ling A, Timmers HJ, Adams KT, Kozupa A, Pacak K.

Brief communication: radiographic contrast infusion and catecholamine release in

patients with pheochromocytoma. Ann Intern Med. 2009 Jan 6;150(1):27-32. Erratum

in: Ann Intern Med. 2009 Feb 17;150(4):292. PubMed PMID: 19124817; PubMed Central

PMCID: PMC3490128.

33: Timmers HJ, Pacak K, Huynh TT, Abu-Asab M, Tsokos M, Merino MJ, Baysal BE,

Adams KT, Eisenhofer G. Biochemically silent abdominal paragangliomas in patients

with mutations in the succinate dehydrogenase subunit B gene. J Clin Endocrinol

Metab. 2008 Dec;93(12):4826-32. doi: 10.1210/jc.2008-1093. Epub 2008 Oct 7.

PubMed PMID: 18840642; PubMed Central PMCID: PMC2626451.

34: Ilias I, Chen CC, Carrasquillo JA, Whatley M, Ling A, Lazúrová I, Adams KT,

Perera S, Pacak K. Comparison of 6-18F-fluorodopamine PET with

123I-metaiodobenzylguanidine and 111in-pentetreotide scintigraphy in localization

of nonmetastatic and metastatic pheochromocytoma. J Nucl Med. 2008

Oct;49(10):1613-9. doi: 10.2967/jnumed.108.052373. Epub 2008 Sep 15. PubMed PMID:

18794260; PubMed Central PMCID: PMC2614907.

35: Lai EW, Perera SM, Havekes B, Timmers HJ, Brouwers FM, McElroy B, Adams KT,

Ohta S, Wesley RA, Eisenhofer G, Pacak K. Gender-related differences in the

clinical presentation of malignant and benign pheochromocytoma. Endocrine. 2008

Aug-Dec;34(1-3):96-100. doi: 10.1007/s12020-008-9108-4. Epub 2008 Nov 4. PubMed

PMID: 18982461.

36: Zelinka T, Timmers HJ, Kozupa A, Chen CC, Carrasquillo JA, Reynolds JC, Ling

A, Eisenhofer G, Lazúrová I, Adams KT, Whatley MA, Widimsky J Jr, Pacak K. Role

of positron emission tomography and bone scintigraphy in the evaluation of bone

involvement in metastatic pheochromocytoma and paraganglioma: specific

implications for succinate dehydrogenase enzyme subunit B gene mutations. Endocrine-Related Cancer. 2008 Mar;15(1):311-23. doi: 10.1677/ERC-07-0217. PubMed PMID:

18310297.

37: Timmers HJ, Carrasquillo JA, Whatley M, Eisenhofer G, Chen CC, Ling A,

Linehan WM, Pinto PA, Adams KT, Pacak K. Usefulness of standardized uptake values

for distinguishing adrenal glands with pheochromocytoma from normal adrenal

glands by use of 6-18F-fluorodopamine PET. J Nucl Med. 2007 Dec;48(12):1940-4.

Epub 2007 Nov 15. PubMed PMID: 18006611.

38: Timmers HJ, Hadi M, Carrasquillo JA, Chen CC, Martiniova L, Whatley M, Ling

A, Eisenhofer G, Adams KT, Pacak K. The effects of carbidopa on uptake of

6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal

paraganglioma. J Nucl Med. 2007 Oct;48(10):1599-606. Epub 2007 Sep 14. PubMed

PMID: 17873132.

39: Timmers HJ, Kozupa A, Chen CC, Carrasquillo JA, Ling A, Eisenhofer G, Adams

KT, Solis D, Lenders JW, Pacak K. Superiority of fluorodeoxyglucose positron

emission tomography to other functional imaging techniques in the evaluation of

metastatic SDHB-associated pheochromocytoma and paraganglioma. J Clin Oncol. 2007

Jun 1;25(16):2262-9. PubMed PMID: 17538171.

40: Timmers HJ, Kozupa A, Eisenhofer G, Raygada M, Adams KT, Solis D, Lenders JW,

Pacak K. Clinical presentations, biochemical phenotypes, and genotype-phenotype

correlations in patients with succinate dehydrogenase subunit B-associated

pheochromocytomas and paragangliomas. J Clin Endocrinol Metab. 2007

Mar;92(3):779-86. Epub 2007 Jan 2. PubMed PMID: 17200167.

41: Brouwers FM, Eisenhofer G, Tao JJ, Kant JA, Adams KT, Linehan WM, Pacak K.

High frequency of SDHB germline mutations in patients with malignant

catecholamine-producing paragangliomas: implications for genetic testing. J Clin

Endocrinol Metab. 2006 Nov;91(11):4505-9. Epub 2006 Aug 15. PubMed PMID:

16912137.

42: Eisenhofer G, Goldstein DS, Sullivan P, Csako G, Brouwers FM, Lai EW, Adams

KT, Pacak K. Biochemical and clinical manifestations of dopamine-producing

paragangliomas: utility of plasma methoxytyramine. J Clin Endocrinol Metab. 2005

Apr;90(4):2068-75. Epub 2005 Jan 11. PubMed PMID: 15644397.

43: Pacak K, Ilias I, Adams KT, Eisenhofer G. Biochemical diagnosis, localization

and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2

in relation to other hereditary syndromes and sporadic forms of the tumour. J

Intern Med. 2005 Jan;257(1):60-8. Review. PubMed PMID: 15606377.

Contact this candidate